Midgard Science

Lotte Biologics

Seoul, South Korea lottebiologics.com From their website, Nov 2026

Work here? Claim this listing

About

LOTTE Biologics is a global contract development and manufacturing organization providing biologics and bioconjugate services across the full product lifecycle. It serves innovators developing programs from early development through commercial supply, with operations in the United States and South Korea.

Services

  • Antibody Development Services

    End-to-end support from cell line development and process development to analytical validation and worldwide regulatory filings.

  • Bioconjugate Development Services

    Integrated antibody manufacturing and bioconjugation support at a single US site.

  • Manufacturing Services

    Flexible, scalable manufacturing support from early development through commercial supply.

    CDMO: development & manufacturing

  • CMC & Quality Management

    Integrated quality, analytical, and regulatory support from early development through commercial manufacturing.

  • Platform Technology

    Proprietary technologies offered to support flexible, customized manufacturing solutions.

  • Cell Line Development

    Cell line development support for biologics programs.

    Cell line development

  • Process Development

    Upstream and downstream process development and technology transfer support for multiple cell lines and biologic modalities.

  • Analytical Development

    Analytical development support for development, validation, and characterization work.

5 more services
  • Bioconjugate Manufacturing
  • Bioconjugate Analytical Support
  • Antibody Manufacturing
  • Analytical Support
  • Regulatory Support
Turnaround
10 months from CLD to IND

Capabilities

Assays and studies
  • Process development
  • Antibodies
  • Analytical development
  • CHO
  • Toxicology
  • Stability studies
9 more
  • ADCs
  • Analytical method development
  • Analytical method validation
  • Analytical method qualification
  • Bioconjugate analytical development
  • Bioconjugate characterization
  • Stability testing
  • Process characterization
  • Method performance trending
Scale and capacity
  • 50L tox run
  • 1.1 kL x4 bioreactors
  • 5 kL x8 bioreactors
  • 3 kL x8 bioreactors
  • 15 kL x8 bioreactors
  • Bioconjugate capacity up to 1000L single use

Instruments and platforms

  • Ambr 250™
  • TFF

Modalities and species

Modalities
  • Antibody
  • Bispecific
  • ADC
  • Peptide
  • Oligonucleotide
  • Recombinant protein
Species and models
  • CHO-S
  • CHO-DG44
  • CHO-K
  • NS0

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

Details

Type
CRDMO
Quality
Global quality framework (US and Korea operations) · inspection readiness · regulatory compliance
Based in
Seoul, South Korea
Sites
  • East Syracuse, NY, USA
  • Incheon, Republic of Korea
  • Songdo-dong, Yeonsu-gu, Incheon, Republic of Korea
Serves
United States, South Korea, worldwide

Public records

FDA drug establishment registration
1317757 · ANALYSIS; API MANUFACTURE source

Similar labs